Cell of origin determines clinically relevant subtypes of MLL-rearranged AML

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Leukemia

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2012.363PMID 23235717PMCID PMC4693300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.

  2013cited by this paper
• Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia

  2012cited by this paper
• Malignant glioma: lessons from genomics, mouse models, and stem cells.

  2012cited by this paper
• Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains.

  2012cited by this paper
• ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways

  2012cited by this paper
• methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles

  2012cited by this paper
• EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.

  2012cited by this paper
• High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.

  2011cited by this paper
• Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications

  2011cited by this paper
• Cells of origin in cancer

  2011cited by this paper
• SLIM: a sliding linear model for estimating the proportion of true null hypotheses in datasets with dependence structures

  2011cited by this paper
• Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype

  2011cited by this paper
• Stem cell gene expression programs influence clinical outcome in human leukemia

  2011cited by this paper
• Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.

  2011cited by this paper
• Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

  2010cited by this paper
• Epigenetic memory in induced pluripotent stem cells

  2010cited by this paper
• Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia

  2010cited by this paper
• Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.

  2010cited by this paper
• DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML

  2010cited by this paper
• Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.

  2010cited by this paper
• Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

  2009cited by this paper
• Impact of new prognostic markers in treatment decisions in acute myeloid leukemia

  2009cited by this paper
• Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.

  2009cited by this paper
• MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

  2009cited by this paper
• The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence

  2009cited by this paper
• Genome-wide determination of DNA methylation by Hpa II tiny fragment enrichment by ligation-mediated PCR (HELP) for the study of acute leukemias.

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Mouse models of human AML accurately predict chemotherapy response.

  2009cited by this paper
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

  2009cited by this paper
• Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.

  2009cited by this paper
• DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction

  2009cited by this paper
• Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

  2009cited by this paper
• Expression and prognostic significance of different mRNA 5′‐end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration

  2008cited by this paper
• An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML.

  2008cited by this paper
• High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

  2008cited by this paper
• Acute myeloid leukemia: the challenge of capturing disease variety.

  2008cited by this paper
• The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.

  2008cited by this paper
• MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment

  2008cited by this paper
• Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

  2008cited by this paper
• Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas

  2008cited by this paper
• MLL translocations, histone modifications and leukaemia stem-cell development

  2007cited by this paper
• Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.

  2007cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.

  2006cited by this paper
• The epigenetic progenitor origin of human cancer

  2006cited by this paper
• Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

  2006cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Gene expression profiling of pediatric acute myelogenous leukemia.

  2004cited by this paper
• MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

  2004cited by this paper
• Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.

  2004cited by this paper
• Prognostically useful gene-expression profiles in acute myeloid leukemia.

  2004cited by this paper
• Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.

  2003cited by this paper
• A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

  2000cited by this paper
• Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell

  1996cited by this paper

• Leukemia stem cell expansion cultures reveal clonal drivers of leukemogenesis and therapy response

  2026cites this paper
• Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia.

  2026cites this paper
• CSF1R marks a subset of foetal haematopoietic multipotent progenitor cells with acute myeloid leukaemia propagation properties

  2026cites this paper
• Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation

  2025cites this paper
• MNT: a new target for AML

  2025cites this paper
• Resolving leukemic stem cell heterogeneity and plasticity with single-cell multiomics.

  2025cites this paper
• SKIDA1 sustains MLL::ENL-expressing hematopoietic progenitors during neonatal stages and promotes B-lineage priming

  2025cites this paper
• Pbx3-mediated suppression of type I interferon response contributes to leukemia progression driven by MLL-AF9

  2025cites this paper
• Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid Leukemia

  2025cites this paper
• Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation

  2025cites this paper
• Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations.

  2025cites this paper
• The EAAT1 aspartate/glutamate transporter is dispensable for acute myeloid leukemia cell growth and response to therapy

  2025cites this paper
• Rapid epigenomic classification of acute leukemia

  2025cites this paper
• 28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease

  2025influential citation
• Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis

  2025cites this paper
• Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome

  2025cites this paper
• Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential

  2024cites this paper
• Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses

  2024cites this paper
• Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML

  2024cites this paper
• The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development

  2024cites this paper
• The epigenetic state of the cell of origin defines mechanisms of leukemogenesis

  2024cites this paper
• Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML

  2024cites this paper
• HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia

  2024cites this paper
• Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer

  2024cites this paper
• A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction

  2024cites this paper
• Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib

  2024cites this paper
• Pre-existing stem cell heterogeneity dictates clonal responses to acquisition of cancer driver mutations

  2024cites this paper
• Cancers make their own luck: theories of cancer origins

  2023cites this paper
• Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia

  2023cites this paper
• Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15

  2023cites this paper
• Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance

  2023cites this paper
• An overview of novel therapies in advanced clinical testing for acute myeloid leukemia

  2023cites this paper
• Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia

  2023cites this paper
• The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression

  2023cites this paper
• The neuronal homeobox transcription factor HMX3 is a crucial vulnerability factor in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia

  2023cites this paper
• Backtracking to the future: unraveling the origins of childhood leukemia

  2023cites this paper
• PACESS: Practical AI-based Cell Extraction and Spatial Statistics for large 3D biological images

  2023cites this paper
• Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML

  2023cites this paper
• Understanding blood development and leukemia using sequencing-based technologies and human cell systems

  2023cites this paper
• Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation

  2023cites this paper
• Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia

  2023cites this paper
• EVI1-mediated Programming of Normal and Malignant Hematopoiesis

  2023cites this paper
• Multiple cells of origin in common with various types of mouse N-Myc acute leukemia.

  2022cites this paper
• Quiescence regulation by normal haematopoietic stem cells and leukaemia stem cells

  2022cites this paper
• Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches

  2022cites this paper
• Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.

  2022cites this paper
• PAX5 alterations in an infant case of KMT2A‐rearranged leukemia with lineage switch

  2022cites this paper
• The Opportunity of Proteomics to Advance the Understanding of Intra- and Extracellular Regulation of Malignant Hematopoiesis

  2022influential citation
• åKrüppel-like factor 4 supports the expansion of leukemia stem cells in MLL-AF9-driven acute myeloid leukemia.

  2022cites this paper
• Epigenetic Inheritance From Normal Origin Cells Can Determine the Aggressive Biology of Tumor-Initiating Cells and Tumor Heterogeneity

  2022cites this paper
• Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

  2022cites this paper
• A practical extraction and spatial statistical pipeline 1 for large 3D bioimages 2

  2022cites this paper
• Viewing AML through a New Lens: Technological Advances in the Study of Epigenetic Regulation

  2022cites this paper
• Murine Models of Acute Myeloid Leukemia

  2022cites this paper
• Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate

  2022cites this paper
• EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment

  2022cites this paper
• Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma

  2022cites this paper
• Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia

  2021cites this paper
• Hepatic Leukemia Factor supports the propagation of leukemia and hematopoietic stem cell function during stress-induced regeneration

  2021cites this paper
• Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models

  2021cites this paper
• Non‐genetic heterogeneity, altered cell fate and differentiation therapy

  2021cites this paper
• ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism

  2021cites this paper
• Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

  2021cites this paper
• Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes

  2021cites this paper
• Non-genetic determinants of malignant clonal fitness at single-cell resolution

  2021cites this paper
• A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia

  2021cites this paper
• Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML

  2021cites this paper
• Reconstruction of Human AML Using Functionally and Immunophenotypically Defined Human Haematopoietic Stem and Progenitor Cells as Targeted Populations.

  2021cites this paper
• Myeloid leukemia vulnerabilities at CTCF-enriched long noncoding RNA loci

  2021cites this paper
• Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes.

  2021influential citation
• DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model

  2021cites this paper
• The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells

  2021cites this paper
• Molecular and Functional Dynamics of Hematopoietic Progenitor Cell Fate During Ontogeny

  2021cites this paper
• Clonal hematopoiesis and risk for hematologic malignancy.

  2020cites this paper
• All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells

  2020cites this paper
• Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.

  2020cites this paper
• BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.

  2020cites this paper
• Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy

  2020cites this paper
• Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention

  2020cites this paper
• Novel therapeutic strategies for MLL-rearranged leukemias.

  2020cites this paper
• Heritable Genetic Background Alters Survival and Phenotype of Mll-AF9-Induced Leukemias

  2020cites this paper
• CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis

  2020cites this paper
• Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

  2020cites this paper
• Myeloid transformation by MLL-ENL depends strictly on C/EBP

  2020cites this paper
• Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML

  2020cites this paper
• TAL1 und miR-17-92 bilden eine regulatorische Schleife in der Hämatopoese

  2020cites this paper
• MLL fusion proteins and transcriptional control.

  2020cites this paper
• The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML

  2020cites this paper
• The MLL/SET family and haematopoiesis☆

  2020cites this paper
• MLL-rearranged infant leukaemia: A 'thorn in the side' of a remarkable success story.

  2020cites this paper
• Converging molecular evolution in acute myeloid leukaemia

  2020cites this paper
• Therapy Response and Outcome Explained by Leukemia Cell of Origin.

  2020cites this paper
• Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition

  2020cites this paper
• Learning from mouse models of MLL fusion gene-driven acute leukemia.

  2020cites this paper
• Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells

  2020cites this paper
• SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.

  2019cites this paper
• Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation

  2019cites this paper
• Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions

  2019influential citation
• CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia

  2019influential citation
• The growing role of epigenetics in childhood cancers.

  2019cites this paper